Vasundhara Rasayans Ltd.
BSE: VRL · Pharmaceuticals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Vasundhara Rasayans Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Vasundhara Rasayan Limited is an Indian manufacturer specialising in active pharmaceutical ingredients and chemical intermediates, particularly antacid salts. The company operates a manufacturing facility in Maharashtra and serves both domestic and international pharmaceutical markets.
Business Model
The company generates revenue by manufacturing and exporting essential raw materials for digestive health medications, including Dried Aluminum Hydroxide Gel and Magnesium Hydroxide. It leverages its manufacturing capabilities in the Roha industrial area to supply global pharmaceutical clients.
- Establishment Year:1987
Growth Outlook
Growth is driven by the company's focus on maintaining global quality standards to expand its footprint in international pharmaceutical markets. Continued demand for digestive health raw materials remains a primary driver for its production output.
Key Risks
- Regulatory Compliance. The company faces risks related to stringent international quality and safety standards required for pharmaceutical ingredient exports.
- Raw Material Price Volatility. Fluctuations in the cost of chemical raw materials can significantly impact the company's operating margins.
- Export Market Dependency. As a significant exporter, the company is vulnerable to geopolitical shifts, currency fluctuations, and changes in international trade policies.
- Environmental Regulations. Operating in the chemical manufacturing sector subjects the company to rigorous environmental compliance and waste management regulations.
Start your research today
Unlock AI insights, financials, peers and live data on Vasundhara Rasayans Ltd. and 5,000+ companies — free.
Key Metrics
REVENUE
₹36 Cr
TTM · standalone
NET PROFIT
₹6 Cr
TTM · standalone
EPS
₹18.34
TTM · standalone
RETURN ON EQUITY
15.8%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
22.3%
TTM · standalone
P/E
9.2x
Q4 FY26 · standalone
EV/EBITDA
4.1x
Q4 FY26 · standalone
EBITDA MARGIN
24.4%
TTM · standalone
NET PROFIT MARGIN
20.9%
Q4 FY26 · standalone
DEBT TO EQUITY
0.0x
Q4 FY26 · standalone
Peers · Pharmaceuticals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Vasundhara Rasayans Ltd.VRL | ₹50 Cr | 8.51 | 5.62 | 5.1% | 24.4% | 15.8% | 22.3% | -14.6% |
Albert DavidALBERTDAVD | ₹513 Cr | 22.73 | 13.48 | 11.4% | 11.0% | 5.8% | 7.5% | +12.1% |
Jenburkt Pharmaceuticals LimitedJENBURPH | ₹463 Cr | 13.31 | 8.46 | — | 32.0% | 17.6% | 23.2% | -4.3% |
Haleos Labs LimitedHALEOSLABS | ₹452 Cr | 28.60 | 12.72 | -3.1% | 13.6% | 7.4% | 10.3% | — |
TranschemTRANSCHEM | ₹424 Cr | 98.76 | 68.07 | -100.0% | 177.7% | 5.3% | 7.0% | +592.6% |
Medicamen BiotecMEDICAMEQ | ₹338 Cr | 33.59 | 15.53 | 24.7% | 11.3% | 4.1% | 6.2% | -27.9% |
As of Q4 FY26
Financials
Vasundhara Rasayans Ltd.
BSE: VRL · Pharmaceuticals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Vasundhara Rasayans Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Vasundhara Rasayan Limited is an Indian manufacturer specialising in active pharmaceutical ingredients and chemical intermediates, particularly antacid salts. The company operates a manufacturing facility in Maharashtra and serves both domestic and international pharmaceutical markets.
Business Model
The company generates revenue by manufacturing and exporting essential raw materials for digestive health medications, including Dried Aluminum Hydroxide Gel and Magnesium Hydroxide. It leverages its manufacturing capabilities in the Roha industrial area to supply global pharmaceutical clients.
- Establishment Year:1987
Growth Outlook
Growth is driven by the company's focus on maintaining global quality standards to expand its footprint in international pharmaceutical markets. Continued demand for digestive health raw materials remains a primary driver for its production output.
Key Risks
- Regulatory Compliance. The company faces risks related to stringent international quality and safety standards required for pharmaceutical ingredient exports.
- Raw Material Price Volatility. Fluctuations in the cost of chemical raw materials can significantly impact the company's operating margins.
- Export Market Dependency. As a significant exporter, the company is vulnerable to geopolitical shifts, currency fluctuations, and changes in international trade policies.
- Environmental Regulations. Operating in the chemical manufacturing sector subjects the company to rigorous environmental compliance and waste management regulations.
Start your research today
Unlock AI insights, financials, peers and live data on Vasundhara Rasayans Ltd. and 5,000+ companies — free.
Key Metrics
REVENUE
₹36 Cr
TTM · standalone
NET PROFIT
₹6 Cr
TTM · standalone
EPS
₹18.34
TTM · standalone
RETURN ON EQUITY
15.8%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
22.3%
TTM · standalone
P/E
9.2x
Q4 FY26 · standalone
EV/EBITDA
4.1x
Q4 FY26 · standalone
EBITDA MARGIN
24.4%
TTM · standalone
NET PROFIT MARGIN
20.9%
Q4 FY26 · standalone
DEBT TO EQUITY
0.0x
Q4 FY26 · standalone
Peers · Pharmaceuticals
As of Q4 FY26